Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07431281
What this trial is testing

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaEsophageal Cancer
AstraZeneca 2,130
Testing effectiveness (Phase 2)Study completedNCT05038306
What this trial is testing

Chinese Medicine WT for Spinocerebellar Ataxia Type 3

Who this might be right for
Ataxia, SpinocerebellarInsulin-Like Growth Factor IMedicine, Chinese Traditional
Changhua Christian Hospital 33
Not applicableLooking for participantsNCT06932614
What this trial is testing

Comparing the Efficacy of Lyophilized Self Growth Factor Versus PRP Injection for Knee OA

Who this might be right for
Knee OsteoarthritisPRP Injection
Tri-Service General Hospital (TSGH) 90
Testing effectiveness (Phase 2)Study completedNCT02609165
What this trial is testing

Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema

Who this might be right for
Retinitis PigmentosaCystoid Macular Edema
Ospedale San Raffaele 45
Early research (Phase 1)Study completedNCT00800436
What this trial is testing

A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females

Who this might be right for
Breast Cancer
Hoffmann-La Roche 66
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00125034
What this trial is testing

Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Neoplasm MetastasisColorectal Cancer
Merck KGaA, Darmstadt, Germany 344
Early research (Phase 1)Study completedNCT00956436
What this trial is testing

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Biogen 40
Not applicableStudy completedNCT03133234
What this trial is testing

Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

Who this might be right for
T790M Positive NSCLC Patients
AstraZeneca 47
Large-scale testing (Phase 3)Study completedNCT00003809
What this trial is testing

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT01641939
What this trial is testing

Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 415
Not applicableEnded earlyNCT00607477
What this trial is testing

Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

Who this might be right for
Treatment Induced Hypertension
University of Chicago 2
Testing effectiveness (Phase 2)Looking for participantsNCT04962867
What this trial is testing

NCCH2006/MK010 Trial (FORTUNE Trial)

Who this might be right for
Advanced or Recurrent Solid TumorsFGFR Gene Alterations
National Cancer Center, Japan 75
Testing effectiveness (Phase 2)Study completedNCT00004700
What this trial is testing

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Who this might be right for
Hyperinsulinism
Children's Hospital of Philadelphia 16
Not applicableNot Yet RecruitingNCT06592157
What this trial is testing

Factors Influencing Wound Healing After Anal Fistula Surgery

Who this might be right for
Anal Fistula Surgery
Taichung Veterans General Hospital 600
Early research (Phase 1)Study completedNCT00801177
What this trial is testing

Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy

Who this might be right for
Solid Tumors
Eli Lilly and Company 60
Large-scale testing (Phase 3)Study completedNCT00073528
What this trial is testing

Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 1,286
Early research (Phase 1)Ended earlyNCT05489679
What this trial is testing

AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Accutar Biotechnology Inc 6
Not applicableStudy completedNCT03699579
What this trial is testing

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

Who this might be right for
Renal Cell Carcinoma MetastaticRenal Cell Carcinoma
Ipsen 28
Early research (Phase 1)Study completedNCT03603379
What this trial is testing

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas

Who this might be right for
Glioblastoma
University Hospital, Basel, Switzerland 9
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation